158 related articles for article (PubMed ID: 6744269)
1. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Fischer PH; Pamukcu R; Bittner G; Willson JK
Cancer Res; 1984 Aug; 44(8):3355-9. PubMed ID: 6744269
[TBL] [Abstract][Full Text] [Related]
2. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Zhen YS; Lui MS; Weber G
Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
[TBL] [Abstract][Full Text] [Related]
3. Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
Fischer PH; Willson JK; Risueno C; Tutsch K; Bruggink J; Ranhosky A; Trump DL
Cancer Res; 1988 Oct; 48(19):5591-6. PubMed ID: 3416312
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
Willson JK; Fischer PH; Tutsch K; Alberti D; Simon K; Hamilton RD; Bruggink J; Koeller JM; Tormey DC; Earhart RH
Cancer Res; 1988 Oct; 48(19):5585-90. PubMed ID: 3416311
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
Grem JL; Fischer PH
Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Jayaram HN; Ardalan B; Deas M; Johnson RK
Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
Meck RA; Clubb KJ; Allen LM; Yunis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
Chen SF; Ruben RL; Dexter DL
Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
[TBL] [Abstract][Full Text] [Related]
9. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
Grem JL; Fischer PH
Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
[TBL] [Abstract][Full Text] [Related]
10. Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
Hindenburg AA; Taub RN; Grant S; Chang G; Baker MA
Cancer Res; 1985 Jul; 45(7):3048-52. PubMed ID: 3859365
[TBL] [Abstract][Full Text] [Related]
11. Biochemical pharmacology of acivicin in rat hepatoma cells.
Lui MS; Kizaki H; Weber G
Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a new antitumor agent, carbetimer.
Ardalan B; Paget GE
Cancer Res; 1986 Nov; 46(11):5473-6. PubMed ID: 3756894
[TBL] [Abstract][Full Text] [Related]
13. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
Smith PG; Marshman E; Calvert AH; Newell DR; Curtin NJ
Semin Oncol; 1999 Apr; 26(2 Suppl 6):63-7. PubMed ID: 10598557
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
[TBL] [Abstract][Full Text] [Related]
15. Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro.
Marshman E; Newell DR; Calvert AH; Dickinson AM; Patel HR; Campbell FC; Curtin NJ
Clin Cancer Res; 1998 Nov; 4(11):2895-902. PubMed ID: 9829758
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
Chan TC; Howell SB
Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Cole PD; Smith AK; Kamen BA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
[TBL] [Abstract][Full Text] [Related]
19. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
20. Prevention of central nervous system toxicity of the antitumor antibiotic acivicin by concomitant infusion of an amino acid mixture.
Williams MG; Earhart RH; Bailey H; McGovren JP
Cancer Res; 1990 Sep; 50(17):5475-80. PubMed ID: 2386952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
